drugset / Trial / NCT00515944
Evaluate the Migration Potential of Xeomin® Compared to Two Other Botulinum Toxin Type A Products
RandomizedSingle-groupDouble-blind
Summary
Xeomin® is a Botulinum neurotoxin type A preparation free of complexing proteins, i.e. free of bacterial proteins other than the active toxin. Injected into the muscle, Xeomin® causes local weakening. Botulinum toxin type A is used for certain neurological and aesthetic treatments. This study will investigate the migration potential of Xeomin®.
Timeline
- Start
- 2007-08
- Primary completion
- 2008-02
- Completion
- 2008-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Botulinum toxin type A | Protein / enzyme biologic | — | Intramuscular |
Indications
No indication recorded.